225 related articles for article (PubMed ID: 16754645)
1. Ube3a expression is not altered in Mecp2 mutant mice.
Jordan C; Francke U
Hum Mol Genet; 2006 Jul; 15(14):2210-5. PubMed ID: 16754645
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3.
Samaco RC; Hogart A; LaSalle JM
Hum Mol Genet; 2005 Feb; 14(4):483-92. PubMed ID: 15615769
[TBL] [Abstract][Full Text] [Related]
3. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets.
Jordan C; Li HH; Kwan HC; Francke U
BMC Med Genet; 2007 Jun; 8():36. PubMed ID: 17584923
[TBL] [Abstract][Full Text] [Related]
4. Ube3a mRNA and protein expression are not decreased in Mecp2R168X mutant mice.
Lawson-Yuen A; Liu D; Han L; Jiang ZI; Tsai GE; Basu AC; Picker J; Feng J; Coyle JT
Brain Res; 2007 Nov; 1180():1-6. PubMed ID: 17936729
[TBL] [Abstract][Full Text] [Related]
5. MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression.
Makedonski K; Abuhatzira L; Kaufman Y; Razin A; Shemer R
Hum Mol Genet; 2005 Apr; 14(8):1049-58. PubMed ID: 15757975
[TBL] [Abstract][Full Text] [Related]
6. MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain.
Balmer D; Arredondo J; Samaco RC; LaSalle JM
Hum Genet; 2002 Jun; 110(6):545-52. PubMed ID: 12107440
[TBL] [Abstract][Full Text] [Related]
7. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
8. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
[TBL] [Abstract][Full Text] [Related]
9. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.
Chang Q; Khare G; Dani V; Nelson S; Jaenisch R
Neuron; 2006 Feb; 49(3):341-8. PubMed ID: 16446138
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
[TBL] [Abstract][Full Text] [Related]
11. Investigation of UBE3A and MECP2 in Angelman syndrome (AS) and patients with features of AS.
Hitchins MP; Rickard S; Dhalla F; Fairbrother UL; de Vries BB; Winter R; Pembrey ME; Malcolm S
Am J Med Genet A; 2004 Mar; 125A(2):167-72. PubMed ID: 14981718
[TBL] [Abstract][Full Text] [Related]
12. Touchscreen learning deficits in Ube3a, Ts65Dn and Mecp2 mouse models of neurodevelopmental disorders with intellectual disabilities.
Leach PT; Crawley JN
Genes Brain Behav; 2018 Jul; 17(6):e12452. PubMed ID: 29266714
[TBL] [Abstract][Full Text] [Related]
13. Altered somatosensory barrel cortex refinement in the developing brain of Mecp2-null mice.
Moroto M; Nishimura A; Morimoto M; Isoda K; Morita T; Yoshida M; Morioka S; Tozawa T; Hasegawa T; Chiyonobu T; Yoshimoto K; Hosoi H
Brain Res; 2013 Nov; 1537():319-26. PubMed ID: 24060648
[TBL] [Abstract][Full Text] [Related]
14. Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome.
De Felice C; Della Ragione F; Signorini C; Leoncini S; Pecorelli A; Ciccoli L; Scalabrì F; Marracino F; Madonna M; Belmonte G; Ricceri L; De Filippis B; Laviola G; Valacchi G; Durand T; Galano JM; Oger C; Guy A; Bultel-Poncé V; Guy J; Filosa S; Hayek J; D'Esposito M
Neurobiol Dis; 2014 Aug; 68(100):66-77. PubMed ID: 24769161
[TBL] [Abstract][Full Text] [Related]
15. Neuroanatomy in mouse models of Rett syndrome is related to the severity of Mecp2 mutation and behavioral phenotypes.
Allemang-Grand R; Ellegood J; Spencer Noakes L; Ruston J; Justice M; Nieman BJ; Lerch JP
Mol Autism; 2017; 8():32. PubMed ID: 28670438
[TBL] [Abstract][Full Text] [Related]
16. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
Amir RE; Van den Veyver IB; Wan M; Tran CQ; Francke U; Zoghbi HY
Nat Genet; 1999 Oct; 23(2):185-8. PubMed ID: 10508514
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of CNPase in a MeCP2 deficient mouse model of Rett syndrome.
Wu W; Gu W; Xu X; Shang S; Zhao Z
Neurol Res; 2012 Mar; 34(2):107-13. PubMed ID: 22334035
[TBL] [Abstract][Full Text] [Related]
18. Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.
Giacometti E; Luikenhuis S; Beard C; Jaenisch R
Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1931-6. PubMed ID: 17267601
[TBL] [Abstract][Full Text] [Related]
19. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
20. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.
Guy J; Hendrich B; Holmes M; Martin JE; Bird A
Nat Genet; 2001 Mar; 27(3):322-6. PubMed ID: 11242117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
